WuXi Biologics (Cayman) Inc. (HKG:2269)
26.00
+1.70 (7.00%)
Feb 21, 2025, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 106.51 billion as of February 21, 2025. Its market cap has increased by 2.98% in one year.
Market Cap
106.51B
Enterprise Value
105.47B
Revenue
18.39B
Ranking
n/a
PE Ratio
40.34
Stock Price
26.00
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 106.51B, an increase of 232.46%. That is a compound annual growth rate of 16.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeiGene | 202.62B |
JD Health International | 112.75B |
Hansoh Pharmaceutical Group Company | 108.72B |
Alibaba Health Information Technology | 92.63B |
Innovent Biologics | 64.38B |
Sinopharm Group | 62.57B |
Sino Biopharmaceutical | 59.83B |
Akeso | 57.53B |